1. Multinational evidence-based recommendations for the use of
methotrexate in rheumatic disorders with a focus on
rheumatoid arthritis: integrating systematic literature research
andexpert opinion of a broad international panel of
rheumatologists in the 3E Initiative. Visser K1, Katchamart W,
Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C,
Carmona L, van der Heijde D, Bijlsma JW,Boumpas DT, Canhao
H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola
EM, Mielants H, Müller-Ladner U, Murphy G,Østergaard M,
Pereira IA, Ramos-Remus C, Valentini G, Zochling J,
DougadosAnn Rheum Dis. 2009 Jul;68(7):1086-93. doi:
10.1136/ard.2008.094474. Epub 2008 Nov 25.
2. Current evidence for the management of rheumatoid arthritis
with glucocorticoids: a systematic literature review informing
the EULAR recommendations for the management of
rheumatoid arthritis Gorter SL1, Bijlsma JW, Cutolo M, GomezReino J, Kouloumas M, Smolen JS, Landewé R.Ann Rheum Dis.
2010 Jun;69(6):1010-4. doi: 10.1136/ard.2009.127332. Epub 2010
May 6.
3. EULAR recommendations for the management of rheumatoid
arthritis with synthetic and biological disease-modifying
antirheumatic drugs: 2013 update. Smolen JS1, Landewé R,
Breedveld FC, Buch M, Burmester G, Dougados M, Emery P,
Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit
M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F,
Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M,
Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A,
Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der
Heijde D. Ann Rheum Dis. 2014 Mar;73(3):492-509. doi:
10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25
4. Recommendations for screening and detection of connectivetissue disease associated pulmonary arterial hypertension.
Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE,
Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R,
Visovatti S, Altorok N, Townsend W, Fitzgerald J, McLaughlin V.
Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38172. [Epub
ahead of print]
5. Expert consensus for performing right heart catheterisation for
suspected pulmonary arterial hypertension in systemic
sclerosis: a Delphi consensus study with cluster analysis .
Jérôme Avouac, Dörte Huscher, Daniel E Furst, Christian F Opitz,
Oliver Distler, Yannick Allanore, for the EPOSS group Ann
Rheum Dis doi:10.1136/annrheumdis-2012-202567. Published
Online First 24 January 2013
6. Revised recommendations on screening for chloroquine and
hydroxychloroquine retinopathy. Marmor MF1, Kellner U, Lai
TY, Lyons JS, Mieler WF; American Academy of Ophthalmology.
Ophthalmology.
2011
Feb;118(2):415-22.
doi:
10.1016/j.ophtha.2010.11.017.
7. Interstitial lung disease in classic and skin-predominant
dermatomyositis: a retrospective study with screening
recommendations. Morganroth PA1, Kreider ME, Okawa J,
Taylor L, Werth VP. Arch Dermatol. 2010 Jul;146(7):729-38. doi:
10.1001/archdermatol.2010.134.
8. Evidence-Based Guidelines for the Use of Immunologic Tests:
Antinuclear Antibody Testing Daniel H. Solomon,1 Arthur J.
Kavanaugh,2 Peter H. Schur,1 and the American College of
Rheumatology ad hoc committee on immunologic testing
guidelines Arthritis & Rheumatism (Arthritis Care & Research)
Vol. 47, No. 4, August 15, 2002, pp 434–444
9. National Institute for Health and Care Excellence Rheumatoid
arthritis The management of rheumatoid arthritis in adults
Issued: February 2009 last modified: August 2013 NICE clinical
guideline 79 guidance.nice.org.uk/cg79
10.Guidelines for Clinical Use of the Antinuclear Antibody Test
and Tests for Specific Autoantibodies to Nuclear Antigens
Arthur Kavanaugh, MD; Russell Tomar, MD; John Reveille, MD;
Daniel H. Solomon, MD, MPH; Henry A. Homburger, MD Arch
Pathol Lab Med—Vol 124, January 2000
11.Guidelines for the Laboratory Use of Autoantibody Tests in the
Diagnosis and Monitoring of Autoimmune Rheumatic Diseases
Renato Tozzoli, MD,1 Nicola Bizzaro, MD,2 Elio Tonutti, MD,3
Danilo Villalta, MD,4 Danila Bassetti, MD,5 Fabio Manoni, MD,6
Anna Piazza, MD,7 Marco Pradella, MD,8 and Paolo Rizzotti,
MD9 Am J Clin Pathol 2002;117:316-324
12.Long-term management of patients taking immunosuppressive
drugs Denise C Hsu, Constance H Katelaris, Australian prescriber
Volume 32 | NUM BER 3 | JUNE 2009
13.Rheumatoid Arthritis: Diagnosis Management and Monitoring
British Columbia Ministry of Health BCCGuidlines.ca Effective
Date: September 30, 2012
14.Assessing, managing and monitoring biologic therapies for
inflammatory arthritis Guidance for rheumatology practitioners
An advisory document prepared by the Royal College of Nursing
Rheumatology BiologicsWorking Party, in conjunction with other
members of the ArthritisMusculoskeletal Alliance October 2009,
second edition
15.Perspectives in lupus nephritis The use of laboratory tests in
diagnosis and monitoring of systemic lupus erythematosus
Renato Alberto Sinico, Bruna Bollini, Ettore Sabadini, Luca Di
Toma, Antonella Radice - Nephrology and Dialysis Unit and
Center of Clinical Immunology and Rheumatology, San Carlo
Borromeo Hospital, Milan - Italy J NEPHROL 2002; 15 (suppl. 6):
S20-S27
16.Recommendations for the use of biologic agents for the
treatment of rheumatic diseases Australian Rheumatology
Association Mona Manghani, Kathie Tymms, Claire Barrett,
Therapeutics Committee, Australian Rheumatology Association
Revised 6 January 2011